Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 23Gastrointestinal 14Head & Neck 11Gynecologic 3Dermatologic 3Sarcoma 2Lymphoid 2Breast 2CNS 1

Conditions

Lymphoma, T-Cell 2Lymphoma, T-Cell, Peripheral 1

Interventions

Cyclophosphamide 886Rituximab 864Vincristine 382Etoposide 381fludarabine 342Cytarabine 341Doxorubicin 340fludarabine phosphate 319Methotrexate 310Dexamethasone 283Prednisone 282Lenalidomide 245Filgrastim 228Melphalan 200Peripheral Blood Stem Cell Transplantation 184Radiotherapy 175Whole-Body Irradiation 172Busulfan 165Mycophenolic Acid 161venetoclax 158Bendamustine Hydrochloride 158Granulocyte Colony-Stimulating Factor 151Tacrolimus 145ibrutinib 144Bortezomib 138obinutuzumab 125Gemcitabine 113Cyclosporine 110Antilymphocyte Serum 103Carmustine 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × endostar protein × Lymphoid × Clear all
NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, T-Cell

NCT00974324 2010-09-15

PTCL

Fudan University

Phase 2 Unknown
15 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡